EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access

Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis

Christopher J Rogers, Robert Harman iD, Mitchell B Sheinkop, Peter Hanson, Mary A Ambach, Tal David, Rahul Desai, Steven Sampson, Danielle Aufierro, Jay Bowen, Gerard Malanga

Stem Cells and Development · 2024

DOI: 10.1089/scd.2024.0008 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Stem Cells and Development, 2024. Verfasst von Christopher J Rogers und 10 weiteren Autor:innen. Beteiligte Einrichtung: San Diego Orthobiologics Medical Group, Carlsbad, California, USA. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteoarthritis, Knee. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsOsteoarthritis, KneeHumansInjections, Intra-ArticularStromal Vascular FractionSubcutaneous FatTreatment OutcomeAgedMiddle AgedFemaleMaleTransplantation, AutologousMesenchymal Stem Cell TransplantationCell- and Tissue-Based Therapy

Stichwörter der Autor:innen

adult stem cellsintra-articular injectionkneemesenchymal stem cellsosteoarthritisstromal vascular fraction

Autor:innen und Institutionen

  • San Diego Orthobiologics Medical Group, Carlsbad, California, USA.
  • Personalized Stem Cells, Poway, California, USA.
  • Cellular Orthopedics, Chicago, Illinois, USA.
  • Grossmont Orthopedic Medical Group, La Mesa, California, USA.
  • Synergy Orthopedics Specialist Group, San Diego, California, USA.
  • Restore PDX, Beaverton, Oregon, USA.

ORCID-Profile: Robert Harman

Zitieren

APA

Rogers, C. J., Harman, R., Sheinkop, M. B., Hanson, P., Ambach, M. A., David, T., Desai, R., Sampson, S., Aufierro, D., Bowen, J., & Malanga, G. (2024). Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis. Stem Cells and Development. https://doi.org/10.1089/scd.2024.0008

Vancouver

Rogers CJ, Harman R, Sheinkop MB, Hanson P, Ambach MA, David T, et al. Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis. Stem Cells and Development. 2024. doi:10.1089/scd.2024.0008

BibTeX
@article{Rogers2024,
  author = {Rogers, Christopher J and Harman, Robert and Sheinkop, Mitchell B and Hanson, Peter and Ambach, Mary A and David, Tal and Desai, Rahul and Sampson, Steven and Aufierro, Danielle and Bowen, Jay and Malanga, Gerard},
  title = {Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis},
  journal = {Stem Cells and Development},
  year = {2024},
  doi = {10.1089/scd.2024.0008}
}
Kostenlos starten →